BeStock  
Stocks › Medical Devices › PRCT

PROCEPT BioRobotics PRCT

US equityMarket cap rank #3227Medical DevicesRobotics
$17.91 +$0.40 (+2.28%)
Pre-market · Oct 8, 9:00 am ET · After hours $17.91 0.00%
Open$17.63
Prev close$17.51
Day range$17.63 – $18.46
Volume1.15M
Market cap$1.03B
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

Technical signals

Trend readStrong downtrend

0 bullish · 7 bearish of 7 signals

IndicatorValueSignalReading
Price vs 20-day average-3.1%BearishTrading below the 20-day average of $18.49
Price vs 50-day average-9.8%BearishTrading below the 50-day average of $19.85
Price vs 200-day average-26.8%BearishTrading below the 200-day average of $24.47
50-day vs 200-day50d below 200dBearishThe 50-day average is below the 200-day average
RSI (14)43.4BearishMomentum leans negative
MACD (12,26,9)-0.78BearishMACD line is below its signal line
Bollinger band position38%BearishInside the 20-day bands

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

Levels & volatility

Moving averages

AverageLevelPrice vs. it
20-day SMA$18.49-3.1%
50-day SMA$19.85-9.8%
200-day SMA$24.47-26.8%

Recent price levels

LevelPrice
20-day high$21.50
20-day low$16.74
60-day high$22.93
60-day low$16.67
Upper Bollinger band$20.82
Lower Bollinger band$16.16

The 50-day average is currently 18.9% below the 200-day average — consistent with a “death cross” (bearish) configuration.

30-day volatility55.8%
Average true range5.37% of price
Max drawdown (1y)-54.9%
Volume (10d vs 90d)0.98x

Discussion

No comments yet — be the first to weigh in on PRCT.

Leave a comment

Scroll to Top